Trust Company of Vermont’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Trust Company of Vermont’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-650	Closed	-$8K	–	972
2016 Q4	$8K	Hold	650	–	–	﹤0.01%	736
2016 Q3	$9K	Hold	650	–	–	﹤0.01%	690
2016 Q2	$5K	Hold	650	–	–	﹤0.01%	725
2016 Q1	$4K	Hold	650	–	–	﹤0.01%	682
2015 Q4	$4K	Hold	650	–	–	﹤0.01%	710
2015 Q3	$4K	Hold	650	–	–	﹤0.01%	727
2015 Q2	$5K	Hold	650	–	–	﹤0.01%	731
2015 Q1	$5K	Hold	650	–	–	﹤0.01%	711
2014 Q4	$4K	Hold	650	–	–	﹤0.01%	755
2014 Q3	$4K	Hold	650	–	–	﹤0.01%	754
2014 Q2	$4K	Hold	650	–	–	﹤0.01%	698
2014 Q1	$5K	Hold	650	–	–	﹤0.01%	681
2013 Q4	$4K	Buy	650 +500	+333%	+$2.7K	﹤0.01%	676
2013 Q3	$3K	Hold	150	–	–	﹤0.01%	671
2013 Q2	$3K	Buy	+150	New	+$2.66K	﹤0.01%	660

Other funds holding ARIA

FPF

FNY Partners Fund New York $185M AUM 32.59% 1-Year Est. Return

Trust Company of Vermont's ARIA Position: Q1 2017 in Review

Trust Company of Vermont sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 650 shares — an estimated $8K sold.

Trust Company of Vermont first reported a position in ARIA in Q2 2013 and held it in 15 quarters. The position peaked at $9K in Q3 2016. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

Trust Company of Vermont reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
Trust Company of Vermont sold 650 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $8K.
Trust Company of Vermont first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 15 quarters.
Trust Company of Vermont's Ariad Pharmaceuticals Inc position peaked at $9K in Q3 2016.
1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Trust Company of Vermont's 13F filing for Q1 2017, filed 4 May 2017.